63 related articles for article (PubMed ID: 29492644)
1. Training and external validation of pre-treatment FDG PET-CT-based models for outcome prediction in anal squamous cell carcinoma.
Frood R; Mercer J; Brown P; Appelt A; Mistry H; Kochhar R; Scarsbrook A
Eur Radiol; 2024 May; 34(5):3194-3204. PubMed ID: 37924344
[TBL] [Abstract][Full Text] [Related]
2. Survival time prediction in patients with high-grade serous ovarian cancer based on
He D; Zhang X; Chang Z; Liu Z; Li B
BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
[TBL] [Abstract][Full Text] [Related]
3. Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.
Garcia N; Ulin M; Yang Q; Ali M; Bosland MC; Zeng W; Chen L; Al-Hendy A
Cells; 2023 Dec; 12(24):. PubMed ID: 38132150
[TBL] [Abstract][Full Text] [Related]
4. Rare Case of Primary Leiomyosarcoma of Bone - Findings on 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Kumar P; Singh P; Parida GK; Singhal T; Ayyanar P; Pavithra R; Agrawal K
Indian J Nucl Med; 2024; 39(1):52-54. PubMed ID: 38817720
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of lymph node-to-primary tumor ratio of PET standardized uptake value for nasopharyngeal carcinoma: a recursive partitioning risk stratification analysis.
Kong FF; Pan GS; Ni MS; Du CR; Hu CS; Ying HM
Ther Adv Med Oncol; 2024; 16():17588359241233235. PubMed ID: 38379851
[TBL] [Abstract][Full Text] [Related]
6. Prediction of 5-year progression-free survival in advanced nasopharyngeal carcinoma with pretreatment PET/CT using multi-modality deep learning-based radiomics.
Gu B; Meng M; Bi L; Kim J; Feng DD; Song S
Front Oncol; 2022; 12():899351. PubMed ID: 35965589
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Heterogeneity Index Derived from Baseline
Liu F; Gu B; Li N; Pan H; Chen W; Qiao Y; Song S; Liu X
Front Oncol; 2022; 12():862473. PubMed ID: 35494037
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.
Żak K; Zaremba B; Rajtak A; Kotarski J; Amant F; Bobiński M
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454875
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head evaluation of [
Gu B; Liu X; Wang S; Xu X; Liu X; Hu S; Yan W; Luo Z; Song S
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2889-2901. PubMed ID: 35113192
[TBL] [Abstract][Full Text] [Related]
10. The Role of Pretreatment
Yao J; Wang Y; Lin Y; Yang Y; Wan J; Gong X; Zhang F; Zhang W; Marks T; Wang S; Jin H; Shan H
Drug Des Devel Ther; 2021; 15():4157-4166. PubMed ID: 34621120
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Blood Inflammatory Markers for the Differentiation of Uterine Leiomyosarcoma from Leiomyoma.
Suh DS; Song YJ; Roh HJ; Lee SH; Jeong DH; Lee TH; Choi KU; Kim KH
Cancer Manag Res; 2021; 13():5001-5011. PubMed ID: 34211296
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of a nomogram with intratumoral heterogeneity derived from
Gu B; Zhang J; Ma G; Song S; Shi L; Zhang Y; Yang Z
BMC Cancer; 2020 Jan; 20(1):37. PubMed ID: 31941465
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma.
Park JY; Lee JW; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
J Gynecol Oncol; 2017 May; 28(3):e28. PubMed ID: 28382795
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
[TBL] [Abstract][Full Text] [Related]
16. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.
Chicklore S; Goh V; Siddique M; Roy A; Marsden PK; Cook GJ
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):133-40. PubMed ID: 23064544
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric PET/CT in oncology.
Singh D; Miles K
Cancer Imaging; 2012 Sep; 12(2):336-44. PubMed ID: 23023069
[TBL] [Abstract][Full Text] [Related]
18. Preoperative [
Lee JW; Park JY; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1309-1316. PubMed ID: 29492644
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
